Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Smoking Cessation 2Weight Gain 1Neoplasms 1Lymphoma 1Heart Failure 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Secondary Prevention × Clear all
NCT05892146 2023-06-07

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

National Cheng-Kung University Hospital

Phase NA Unknown
100 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

NCT01352000 2017-02-23

Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
3,830 enrolled

Smoking Cessation

NCT01305447 2014-12-16

Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention

University of Western Ontario, Canada

Phase 2 Completed
413 enrolled

Neoplasms, Weight Gain, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡